Working together, we can create successful new generics partnerships. Combining innovative business models with collaborative process development helps to strengthen our customers’ products, while reducing your risk. Our APIs and life cycle management offering is supported by our network of development and commercial manufacturing facilities in Europe, North America and Asia, to meet your global product requirements.

We offer an extensive range of generic APIs and invaluable expertise for developing many more. Risk reduction is ensured through partnering with us and our smart technologies and complex chemistries can help to strengthen IP to ensure a competitive position in the market.


Download API and Controlled Substance Product Guide

API products

Filter by:

Apomorphine HCl

CAS number: 41372-20-7
See more

Atropine Sulfate

CAS number: 5908-99-6
See more


CAS number: 34031-32-8
See more


CAS number: 1187594-09-7
See more


CAS number: 41575-94-4
See more


CAS number: 154-93-8
See more


CAS number: 15663-27-1
See more


CAS number: 2353-33-5
See more


CAS number: 115256-11-6
See more

Edrophonium Chloride

CAS number: 116-38-1
See more

Isoproterenol HCl

CAS number: 51-30-9
See more


CAS number: 191732-72-6
See more

Lurasidone HCl

CAS number: 367514-88-3
See more


CAS number: 72599-27-0
See more

Naloxone HCl

CAS number: 51481-60-8
See more


CAS number: 656247-18-6
See more


CAS number: 53179-13-8
See more


CAS number: 19171-19-8
See more


CAS number: 737789-87-6
See more


CAS number: 1393477-72-9
See more


CAS number: 1257044-40-8
See more


CAS number: 879085-55-9
See more


CAS number: 1446321-46-5
See more

Controlled substances

Learn more

Featured insights from our experts

Read more

Improving solubility and accelerating drug development

Drug solubility plays a fundamental role in ensuring therapeutic efficacy. Drugs that are poorly water soluble…

The importance of chirality in API development

The chirality of a molecule can influence key pharmacological activities, which impact a drug’s tolerability, safety, and bioavailability.

Early form screening strategies to accelerate candidate selection

Failure to select a successful candidate can be expensive in terms of both time and money.

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us